83
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Two forms of long-term potentiation induced by different compounds

, , &
Pages 217-222 | Received 03 Dec 2004, Accepted 08 Dec 2005, Published online: 04 Mar 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jin-Feng Hu, Fei Niu, Na Ning, Wen-Zhen Duan, Shi-Feng Chu, Wei Xue, Yu-He Yuan, Nai-Hong Chen & Jun-Tian Zhang. (2012) Activation of ERK1/2-CREB pathway during potentiating synaptic transmission of ( − )clausenamide in rat dentate gyrus. Journal of Asian Natural Products Research 14:3, pages 256-262.
Read now

Articles from other publishers (4)

O. A. Bocharova, R. V. Karpova, E. V. Bocharov, A. A. Vershinskaya, M. A. Baryshnikova, I. V. Kazeev, V. G. Kucheryanu & M. V. Kiselevskiy. (2020) PHYTOADAPTOGENS IN THE TUMOURS BIOTHERAPY AND GERIATRICS (PART 2). Russian Journal of Biotherapy 19:3, pages 12-20.
Crossref
Mehdy Ghaeminia, Ramamoorthy Rajkumar, Hwee-Ling Koh, Gavin S. Dawe & Chay Hoon Tan. (2018) Ginsenoside Rg1 modulates medial prefrontal cortical firing and suppresses the hippocampo-medial prefrontal cortical long-term potentiation. Journal of Ginseng Research 42:3, pages 298-303.
Crossref
Shifeng Chu, Shaolin Liu, Wenzhen Duan, Yong Cheng, Xueying Jiang, Chuanjiang Zhu, Kang Tang, Runsheng Wang, Lin Xu, Xiaoying Wang, Xiaoming Yu, Kemei Wu, Yan Wang, Muzou Wang, Huiyong Huang & Juntian Zhang. (2016) The anti-dementia drug candidate, (−)-clausenamide, improves memory impairment through its multi-target effect. Pharmacology & Therapeutics 162, pages 179-187.
Crossref
Na Ning, Jiandong Sun, Guohua Du, Ning Han, Juntian Zhang & Naihong Chen. (2012) (+)-epi-Clausenamide, but not (−)-epi-clausenamide, showed more potential than (−)-clausenamide on facilitating synaptic transmission in CA1 region of hippocampal synapses. Neuroscience Letters 523:2, pages 99-103.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.